TAMPA, Florida. You have probably already heard of the drug Ozempic, used to treat diabetes. But along the way, doctors discovered that it also helped patients lose weight by reducing their cravings. This drug, in high demand, is causing supply shortages around the world. Now, there’s a new warning from… Continue Reading Fake Ozempic pens contain insulin, worrying health officials
Health By Adriana Diaz Published November 8, 2023, 3:40 p.m. ET The Food and Drug Administration is investigating several hospitalizations and deaths potentially linked to counterfeit semaglutide drugs, such as Ozempic, according to multiple reports. At least three Americans have been hospitalized after injecting themselves with suspected counterfeit products, CBS… Continue Reading FDA investigating deaths, hospitalizations caused by fake Ozempic: reports
The Food and Drug Administration on Wednesday has approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that in clinical trials has been shown to help people lose up to 52 pounds in 16 months. Related to Zep is the latest entrant in the field of powerful new… Continue Reading FDA Approves Eli Lilly’s Weight Loss Drug That Helped People Lose Up to 52 Pounds
The Food and Drug Administration on Wednesday has approved Zepbound, a new weight loss drug from drugmaker Eli Lilly that in clinical trials has been shown to help people lose up to 52 pounds in 16 months. Related to Zep is the latest entrant in the field of powerful new… Continue Reading FDA approves Eli Lillys Zepbound, a weight loss drug similar to Ozempic and Wegovy
American doctors finally have a new option for treating high blood pressure (hypertension) that remains insufficiently controlled despite medication and lifestyle changes. The FDA has approved Recor Medical’s Paradise Ultrasound Renal Denervation (RDN) System. The Palo Alto, Calif.-based company’s RDN system is designed to lower blood pressure by denervating the… Continue Reading FDA approves renal denervation for high blood pressure
At least three Americans were reportedly hospitalized after using suspected counterfeit semaglutide medications, including Novo Nordisk’s diabetes drug Ozempic, according to records released by the Food and Drug Administration. Ozempic and Wegovy, another semaglutide drug from Novo Nordisk, have been in shortage for months amid booming sales for their use… Continue Reading FDA investigating reports of hospitalizations after fake Ozempic
In a new study, researchers found that four of the five original studies on the effectiveness of alprazolam (Xanax) did not show it to be better than placebo. Two of the negative studies remain unpublished, while two others were presented as positive upon publication despite the drugs’ failure to beat… Continue Reading Only one of five key Xanax trials deemed positive by FDA
The U.S. Food and Drug Administration (FDA) has approved vonoprazan tablets 10 mg and 20 mg (Voquezna, Phathom Pharmaceuticals) for the cure and maintenance of healing of all grades of erosive esophagitis, also known as erosive gastroesophageal reflux disease (GERD), as well as relief from associated heartburn, the company announced.… Continue Reading FDA approves new treatment for erosive esophagitis
Stelara is an interleukin-12 and interleukin-23 antagonist used for the treatment of plaque psoriasis, psoriatic arthritis, Crohn’s disease and ulcerative colitis. The original product is available in intravenous and subcutaneous formulations. The FDA has approved Wezlana (ustekinumab-auub), making it the first approval for blockbuster biosimilar drug Stelara (ustekinumab). The agency… Continue Reading FDA approves first Stelara biosimilar, Wezlana
The U.S. Food and Drug Administration (FDA) approved Phathom Pharmaceuticals’ vonoprazan (Voquenza) on November 1, 2023 for the treatment of adults with erosive esophagitis (erosive GERD), a gastroesophageal reflux disease. The drug is expected to be commercially available by December 2023. The drug’s approval marks a critical moment for more… Continue Reading FDA approves Vonoprazan to treat erosive esophagitis